ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,770Medicare Part D Prescriptions Filled, Including Refills

Rank: 237 out of 780

$454K Total Retail Price of All Prescriptions

Rank: 328 out of 780

412 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 8,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 624 478 1 5
HYDROCODONE-ACETAMINOPHEN 526 294 S3 2 1
PRAVASTATIN SODIUM 385 304 3 9
AMLODIPINE BESYLATE 381 319 4 4
GABAPENTIN 333 209 5 13
OMEPRAZOLE 303 207 6 3
METFORMIN HCL 297 186 7 8
HYDROCHLOROTHIAZIDE 254 215 8 10
SIMVASTATIN 218 177 9 2
CARVEDILOL 215 171 10 14
FUROSEMIDE 209 176 11 7
GLIMEPIRIDE 192 141 12 30
ATORVASTATIN CALCIUM 187 155 13 12
LISINOPRIL 180 138 14 6
ATENOLOL 178 166 15 21
SERTRALINE HCL 170 119 16 27
MELOXICAM 167 127 17 16
PANTOPRAZOLE SODIUM 164 109 18 25
CITALOPRAM HBR 159 131 19 23
METOPROLOL SUCCINATE 152 119 20 20
FAMOTIDINE 151 113 21 86
NEXIUM 136 76 22 22
METOPROLOL TARTRATE 132 104 23 19
CLONIDINE HCL 126 96 24 28
RAMIPRIL 123 85 25 70
LOVASTATIN 119 98 26 47
WARFARIN SODIUM 115 94 27 24
FLUOXETINE HCL 112 55 28 65
SPIRONOLACTONE 107 79 29 53
TRIAMTERENE-HCTZ 105 81 30 37
LOSARTAN POTASSIUM 104 88 31 18
LOSARTAN-HYDROCHLOROTHIAZIDE 99 69 32 33
QUINAPRIL HCL 95 70 33 113
POTASSIUM CHLORIDE 95 79 33 11
AZITHROMYCIN 94 61 35 38
DONEPEZIL HCL 93 93 36 31
PROAIR HFA 90 52 37 62
ZOLPIDEM TARTRATE 82 75 38 17
TRAZODONE HCL 81 47 39 35
METHOCARBAMOL 79 34 R 40 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 61 41 26
BUPROPION HCL SR 71 51 42 193
FLUTICASONE PROPIONATE 63 37 43 41
AMOXICILLIN 60 48 44 99
CYMBALTA 59 30 45 51
BENAZEPRIL HCL 59 44 45 59
ROPINIROLE HCL 57 42 47 87
LEVETIRACETAM 57 28 47 130
HYDRALAZINE HCL 57 57 47 54
METFORMIN HCL ER 56 49 50 43
FENOFIBRATE 56 45 50 63
KLOR-CON 10 55 42 52 90
NAPROXEN 55 42 52 100
ESTRADIOL 53 48 R 54 122
PROPRANOLOL HCL 53 39 54 133
ALLOPURINOL 51 23 56 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.